BLEPHAMIDE is a Ophthalmic Ointment in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Sulfacetamide Sodium; Prednisolone Acetate.
Product ID | 0023-0313_376f9d35-04d0-4089-b303-99c0d7671ae7 |
NDC | 0023-0313 |
Product Type | Human Prescription Drug |
Proprietary Name | BLEPHAMIDE |
Generic Name | Sulfacetamide Sodium And Prednisolone Acetate |
Dosage Form | Ointment |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 1987-01-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA087748 |
Labeler Name | Allergan, Inc. |
Substance Name | SULFACETAMIDE SODIUM; PREDNISOLONE ACETATE |
Active Ingredient Strength | 100 mg/g; mg/g |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Sulfonamide Antibacterial [EPC],Sulfonamides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1987-01-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA087748 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 1987-01-01 |
Ingredient | Strength |
---|---|
SULFACETAMIDE SODIUM | 100 mg/g |
SPL SET ID: | c68ebddc-dcb5-4695-a66b-d03a65a110f6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0023-0313 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate |
11980-022 | BLEPHAMIDE | sulfacetamide sodium and prednisolone acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BLEPHAMIDE 72119340 0724725 Live/Registered |
Allergan Pharmaceuticals, Inc. 1961-05-05 |